MATERAZZI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 24.342
AS - Asia 11.437
EU - Europa 10.751
SA - Sud America 1.617
AF - Africa 557
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 48.725
Nazione #
US - Stati Uniti d'America 23.677
IT - Italia 4.537
SG - Singapore 3.811
CN - Cina 3.132
HK - Hong Kong 1.841
DE - Germania 1.430
BR - Brasile 1.357
SE - Svezia 1.300
VN - Vietnam 995
BG - Bulgaria 661
GB - Regno Unito 568
FR - Francia 481
CA - Canada 475
TR - Turchia 446
FI - Finlandia 444
RU - Federazione Russa 339
IN - India 260
UA - Ucraina 223
AT - Austria 221
CI - Costa d'Avorio 210
JP - Giappone 199
NL - Olanda 152
KR - Corea 149
BD - Bangladesh 117
SN - Senegal 102
MX - Messico 98
CH - Svizzera 91
IQ - Iraq 85
AR - Argentina 69
PK - Pakistan 58
ZA - Sudafrica 58
MA - Marocco 56
PL - Polonia 51
ES - Italia 50
SA - Arabia Saudita 48
ID - Indonesia 47
EC - Ecuador 41
BE - Belgio 39
CO - Colombia 38
NG - Nigeria 37
UZ - Uzbekistan 37
VE - Venezuela 36
CL - Cile 24
CZ - Repubblica Ceca 23
KE - Kenya 23
JO - Giordania 20
PH - Filippine 19
IL - Israele 18
IE - Irlanda 17
IR - Iran 17
LT - Lituania 17
PY - Paraguay 17
MY - Malesia 16
NP - Nepal 16
TN - Tunisia 16
JM - Giamaica 15
DZ - Algeria 14
EE - Estonia 14
EG - Egitto 14
HU - Ungheria 13
PE - Perù 12
PT - Portogallo 11
AL - Albania 10
BO - Bolivia 10
CR - Costa Rica 10
GR - Grecia 10
HN - Honduras 10
LB - Libano 10
PA - Panama 10
RO - Romania 10
UY - Uruguay 10
AU - Australia 9
AZ - Azerbaigian 9
KG - Kirghizistan 9
NI - Nicaragua 9
OM - Oman 9
TT - Trinidad e Tobago 9
TW - Taiwan 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
PS - Palestinian Territory 8
RS - Serbia 7
BB - Barbados 6
BY - Bielorussia 6
DK - Danimarca 6
BJ - Benin 5
ET - Etiopia 5
LK - Sri Lanka 5
SV - El Salvador 5
BH - Bahrain 4
GT - Guatemala 4
MK - Macedonia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AO - Angola 3
EU - Europa 3
GA - Gabon 3
GY - Guiana 3
Totale 48.668
Città #
Ashburn 2.605
Dallas 2.310
Singapore 2.142
Hong Kong 1.805
Woodbridge 1.786
Fairfield 1.753
San Jose 1.508
Houston 1.285
Chandler 1.280
Ann Arbor 1.221
Santa Clara 1.109
Milan 779
Seattle 718
Shanghai 692
Sofia 648
Beijing 613
Wilmington 608
Cambridge 606
New York 531
Serra 403
Los Angeles 386
Boardman 378
Ottawa 336
Princeton 306
Lawrence 266
Ho Chi Minh City 262
Izmir 256
Jacksonville 251
Lauterbourg 245
Florence 244
Munich 241
Rome 241
Medford 228
Abidjan 210
Hefei 208
Nanjing 200
Vienna 193
Council Bluffs 184
Pisa 183
Tokyo 181
Hanoi 173
London 156
Des Moines 152
Frankfurt am Main 147
Seoul 139
Helsinki 136
Buffalo 133
Dong Ket 132
São Paulo 131
Istanbul 123
Redondo Beach 122
Dearborn 111
San Diego 103
Turku 103
Dakar 102
Columbus 77
Bern 72
Naples 67
Bremen 65
Nanchang 64
Ogden 61
The Dalles 59
Piscataway 56
Redwood City 56
Kunming 54
Lancaster 54
Chicago 50
Atlanta 49
Bologna 49
Jüchen 47
Orem 47
Hebei 44
Paris 44
Changsha 43
Düsseldorf 43
Boulder 42
Lucca 40
Rio de Janeiro 40
Chennai 39
Haiphong 39
Shenyang 39
Guangzhou 38
Montreal 38
Phoenix 38
San Francisco 38
Brooklyn 37
Falls Church 36
Warsaw 36
Washington 36
Baghdad 35
Belo Horizonte 35
Brussels 35
Cascina 34
Lagos 34
Nuremberg 34
Toronto 34
Amsterdam 33
Denver 33
Fuzhou 33
Tashkent 33
Totale 33.374
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.171
Fistole del seno piriforme in un adolescente 949
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 341
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 319
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 276
Acquired Carotid-Jugular Fistula: Its Changing History and Management 272
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 271
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 255
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 253
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 248
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 246
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 237
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 237
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 229
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 227
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 227
Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed. 226
Sorafenib in the treatment of thyroid cancer 226
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 226
Minimally invasive video-assisted thyroidectomy (MIVAT) from A to Z 225
Aggressive thyroid cancer: targeted therapy with sorafenib 224
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 221
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 217
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 215
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 215
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 214
Sorafenib and Thyroid Cancer 213
Energy-based devices in thyroid surgery-an overview 213
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 212
A pandemic recap: lessons we have learned 209
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 208
Evaluation of a new ultrasonic device in thyroid surgery: comparative randomized study 208
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 207
Minimally invasive video-assisted thyroidectomy (MIVAT) 207
Minimally invasive thyroidectomy in the treatment of well differentiated thyroid cancers: indications and limits 204
The effect of robot-assisted transaxillary thyroidectomy (RATT) on body image is better than the conventional approach with cervicotomy: a preliminary report 202
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 201
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 201
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 199
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 199
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 197
Selective use of vandetanib in the treatment of thyroid cancer 196
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
Modified lateral neck lymphadenectomy: prospective randomized study comparing harmonic scalpel with clamp-and-tie technique 193
Cabozantinib in Thyroid Cancer 193
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 192
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied 190
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 189
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 189
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 189
Video-assisted thyroidectomy: indications and results 188
The extent of surgery in thyroglossal cyst carcinoma 186
Persistent primary hyperparathyroidism caused by an ectopic adenoma in the piriform sinus: case report and review of the literature 185
Radiofrequency Ablation in the Treatment of Benign Thyroid Nodules: An Efficient and Safe Alternative to Surgery 184
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 184
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 183
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 182
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 180
Silent Pheocromocytoma presenting as tako-Tsubo syndrom during anesthesiological stress. 177
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 177
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 177
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 177
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 177
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 177
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 176
Evaluation of a preoperative pain score in response to pressure as a marker of postoperative pain and drugs consumption in surgical thyroidectomy. 175
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 175
Conservative management of a tracheal leakage occurring 40 days after robotic thyroidectomy 175
Novel treatments for anaplastic thyroid carcinoma 174
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion 174
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 173
Track Recurrence after Robotic Transaxillary Thyroidectomy: A Case Report Highlighting the Importance of Controlled Surgical Indications and Addressing Unprecedented Complications 173
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 173
Impact of energy-based devices in pediatric thyroid surgery 173
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 172
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 171
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 171
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 170
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center 170
Tailored surgery according to molecular analysis in differentiated thyroid carcinomas 170
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 170
Minimally Invasive Video-Assisted Parathyroidectomy: Lesson Learned from 137 cases 169
Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management 169
Minimally Invasive Videoassisted thyroidectomy 168
Factors associated with postoperative hypocalcemia following thyroidectomy in childhood 168
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 167
Postoperative Pain Evaluation After Robotic Transaxillary Thyroidectomy Versus Conventional Thyroidectomy: A Prospective Study 166
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 166
Peduncolated adenomas with invasive carcinoma removed endoscopically . Is it necessary surgical treatment? 165
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. 165
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 165
Prevention and management of bleeding in thyroid surgery 165
Impact of harmonic scalpel on operative time during video-assisted thyroidectomy 165
In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features 164
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 164
Endoscopic Parathyroidectomy 163
Early surgery: a favorable prognosticator in amiodarone-induced thyrotoxicosis-a single-center experience with 53 cases 162
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 162
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 162
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 162
Totale 21.380
Categoria #
all - tutte 142.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.042 75 144 101 184 557 440 73 137 169 98 180 884
2022/20234.192 484 546 286 348 447 500 61 337 741 48 318 76
2023/20243.450 357 318 391 296 478 563 193 135 107 87 196 329
2024/202510.279 135 385 155 600 893 1.054 861 568 1.085 1.330 1.117 2.096
2025/202613.588 881 1.740 2.032 1.107 1.230 1.139 2.001 576 647 1.342 446 447
2026/2027178 178 0 0 0 0 0 0 0 0 0 0 0
Totale 49.412